Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

3.1.1.4: phospholipase A2

This is an abbreviated version!
For detailed information about phospholipase A2, go to the full flat file.

Word Map on EC 3.1.1.4

Reaction

phosphatidylcholine
+
H2O
=
1-acylglycerophosphocholine
+
a carboxylate

Synonyms

1-CysPrx, 1-cysteine peroxiredoxin, 14 kDa phospholipase A2, A2-IIA, Acanmyotoxin-1, acidic Asp49 phospholipase A2, acidic Ca2+-independent phospholipase A2, acidic phospholipase A2, ACS, adiponutrin, AdPLA, Agkistrotoxin, AgkTx-II, aiPLA2, alpha-type phospholipase A2, amdI1, Ammodytin I2, ammodytoxin A, APLA, APP-D-49, Arg49 phospholipase A2, Arg49 phospholipase A2 homologue, Asp49 basic myotoxic PLA2, Asp49 PLA2, Asp49-PLA2, ASPLA1, ASPLA10, ASPLA11, ASPLA12, ASPLA13, ASPLA14, ASPLA15, ASPLA16, ASPLA17, ASPLA2, ASPLA3, ASPLA4, ASPLA5, ASPLA6, ASPLA7, ASPLA8, ASPLA9, Ats-PLA2-alpha, AtsPLA2-alpha, AtsPLA2-gamma, ATX, BaltPLA2, basic Asp49 PLA2, Basic protein I/II, BaTX, BinTx-I, BinTx-II, BJ-PLA2, Bj-V, BJUPLA2, Bothropstoxin-I, BPI/BPII, BthTX, BthTX-1, BthTX-I, BthTX-II, bvPLA2, Ca+2-independent PLA2, Ca2+ independent PLA2, Ca2+-independent iPLA2, Ca2+-independent phospholipase A2, Ca2+-independent PLA2, CaI-PLA2, calcium-d-independent cytosolic PLA2, calcium-dependent cytosolic PLA2, calcium-independent group VIA iPLA2, calcium-independent phospholipase A2, Caudoxin, Cdt PLA2, class XIB phospholipase A2, ColTx-I, cPLA2, cPLA2 alpha, cPLA2-alpha, cPLA2-gamma, cPLA2-zeta2, cPLA2alpha, cPLA2beta, cPLA2delta, cPLA2epsilon, cPLA2zeta, cPm09, Cr-IV 1, Cro, crotapotin, crotoxin, CTX, cytoplasmic phospholipase A2, cytosolic calcium-dependent PLA2, cytosolic cPLA2, cytosolic gIVaPLA2, cytosolic group IVA cPLA2, cytosolic group IVa phospholipase A2, cytosolic phospholipase A2, cytosolic phospholipase A2 alpha, cytosolic phospholipase A2-alpha, cytosolic phospholipase A2alpha, cytosolic PLA2, cytotoxin ExoU, Daboxin P, DrK-aI, DrK-aII, DrK-bI, DrK-bII, DrPLA2, DsM-bI, DsM-S1, Enhancing factor, exoenzyme U, ExoU, ExoU-specific PLA2, GIA cobra venom PLA2, GIIA, GIIA PLA2, GIIA sPLA2, GIIC sPLA2, GIID, GIID sPLA2, GIIE, GIIE sPLA2, GIIF, GIIF sPLA2, GIII sPLA2, GIIIsPLA2, GIVA, GIVA cPLA2, GIVA phospholipase A2, GIVA PLA2, GIVD cPLA2delta, GIVF, Gln49-PLA2, group IA PLA2, Group IB phospholipase A2, group IB PLA2, group II snake venom phospholipase A2, Group IIA phospholipase A2, group IIA PLA2, group IIA secretory phospholipase A2, group IIA secretory PLA2, group IID secretory phospholipase A2, group III Glu62-phospholipase A2, group III PLA2, group III sPLA2, group IV cPLA2, group IVA cPLA2, group IVA cytosolic phospholipase A2, group IVA phospholipase A2, group IVA PLA2, group IVB phospholipase A2, Group V phospholipase A2, group V secreted phospholipase A2, Group VI phospholipase A2, Group VIA Ankyrin-1, Group VIA Ankyrin-2, group VIA calcium-independent phospholipase A, group VIA cPLA2, group VIA phospholipase A2, Group VIA PLA2, Group VIA-3, group X secreted phospholipase A2, GS2, GV sPLA2, GVI PLA2, GVIA, GVIA iPLA2, GVIA PLA2, GVIA-iPLA2, GVIIA PLA2, GX, GX sPLA2, GXII sPLA2, GXIIA, GXIII sPLA2, hGX sPLA2, hIBPLA2, hIIAPLA2, human group IB PLA2, human group IIA phospholipase A2, IB PLA2, immune-associated phospholipase A2, imperatoxin, intercro, IPLA-1, iPLA2, iPLA2-gamma, jerdoxin, lecithinase A, lipoprotein associated phospholipase A2, lipoprotein-associated phospholipase A2, lipoprotein-associated PLA2, LLPL, LM-PLA2-I, LM-PLA2-II, LmTX-I, LmTX-II, Lp-PLA2, Lpla2, Lys49 phospholipase A2 homologue, Lys49-phospholipase A2 homologue, Lys49-PLA2, lysophospholipase, lysosomal phospholipase A2, lysosomal PLA2, mAoPlaA, marine snail digestive phospholipase A2, megacin A-216, MiDCA1, milleporin-1, MjTX-II, More, MP-III 4R, mSDPL, MsPLA2-I, Muscarinic inhibitor, mycotoxin II, myotoxic Asp49-phospholipase A2, myotoxic phospholipase A2, Myotoxin, myotoxin I, NAJPLA-2A, NAJPLA-2B, NAJPLA-2C, natratoxin, neuropathy target esterase, neutral anticoagulant secretory phospholipase A2, Nigexine, NK-PLA2-I, NK-PLA2-II, NN-X-PLA2, NN-XI-PLA2, NN-XIa-PLA2, NND-IV-PLA2, Non-pancreatic secretory phospholipase A2, Notechis 11'2, Notexin, notexinII-1, NPLA, NPS-PLA2, OHV A-PLA2, OHV-APLA2, OPLA2, PAF acetyl hydrolase/oxidized lipid LpPLA2, PAF-AH, pancreatic phospholipase A2, pancreatic-type PLA2, patatin, peroxiredoxin 6, pgPLA 1a/pgPLA 2a, PhlA, phosphatidase, phosphatide 2-acylhydrolase, phosphatidolipase, Phosphatidylcholine 2-acylhydrolase, Phosphatidylcholine 2-acylhydrolase GIIC, Phosphatidylcholine 2-acylhydrolase GIID, Phosphatidylcholine 2-acylhydrolase GIIE, Phosphatidylcholine 2-acylhydrolase GIIF, Phosphatidylcholine 2-acylhydrolase GIII, Phosphatidylcholine 2-acylhydrolase GX, Phosphatidylcholine 2-acylhydrolase GXII, Phosphatidylcholine 2-acylhydrolase GXIII, phospholipase A, phospholipase A2, phospholipase A2 D49, phospholipase A2 gamma, Phospholipase A2 inhibitor, phospholipase A2 neurotoxin, phospholipase A2 PA-11, phospholipase A2alpha, phospholipase A2IValpha, phospholipase A2s, phospholipin, pkP5, Pla, PLA1, PLA2, PLA2 CM2, PLA2 neurotoxin, PLA2-10, PLA2-1B, PLA2-2A, PLA2-2C, PLA2-H, PLA2-I, PLA2-L, PLA2-V, PLA2-VI, PLA2-VII, PLA2alpha, PLA2G1B, PLA2G2D, Pla2g4a, Pla2g4b, PLA2G4C, PLA2G4D, PLA2G6, PLA2IID, PLA2III, PLA2IValpha, PLA2s, platelet activating factor acetyl hydrolase, platelet activating factor acetyl hydrolase/oxidized lipid LpPLA2, platelet-activating factor acetylhydrolase, platlet-activating factor acetylhydrolase, plpA, ppPLA2, Prdx6, promutoxin, PrTX-1, PrTX-I, PrTX-III, Pt-PLA1, Pt-PLA2, R49 PLA2, RVV acidic PLA2-I, RVV-7, RVVA-PLA2-I, SCO1048 protein, Scol/Pla, secreted group IID phospholipase A2, secreted human phospholipase A2, secreted phospholipase A2, secreted phospholipaseA2 neurotoxin, secreted phospholipases A2, secreted PLA2, secreted sPLA2, secretory Ca2+-dependent PLA2, secretory phospholipase, secretory phospholipase A2, secretory phospholipase A2 group IIA, secretory phospholipase A2 type IB, secretory phospholipase A2 type IIA, secretory phospholipase A2-alpha, secretory PLA2s, Secretory-type PLA, stroma-associated homolog, snake presynoptic phospholipase A2 neurotoxin, SPAN, specific phospholipase A2, sPLA(2), sPLA(2)-IID, sPLA(2)-IIE, sPLA(2)-IIF, sPLA-V, sPLA2, sPLA2 GIB, sPLA2 GIIA, sPLA2 IB, sPLA2 type IIA, sPLA2(IIA), sPLA2-IB, sPLA2-IIA, sPLA2-IID, sPLA2-IIE, sPLA2-IIF, sPLA2-V, sPLA2-X, sPLA2:, sPLA2IB2, svPLA2, taipoxin, textilotoxin, thrombin inhibitor from Naja haje, TI-Nh, TMV-K49, toxin I, Toxin VI, Toxin VI:5, TPP, trimorphin, TTS-2.2, Tx-1, TX-I, type III cytotoxin, type VIIA PLA2, zhaoermiatoxin

ECTree

     3 Hydrolases
         3.1 Acting on ester bonds
             3.1.1 Carboxylic-ester hydrolases
                3.1.1.4 phospholipase A2

Purification

Purification on EC 3.1.1.4 - phospholipase A2

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
PURIFICATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
3 isoforms: MiPLA-2, MiPLA-3 and MiPLA-4
-
30000fold from rat brain, 90% pure protein
-
4 isoforms: SIIISPIIA, SIIISPIIB, SIIISPIIIA, SIIISPIIIB
-
all steps are performed at 4°C, precipitation, gel filtration
ammonium sulfate fractionation, column chromatography
-
ammonium sulfate precipitation, ethanol fractionation, Mono-S Sepharose column chromatography, Sephadex G-50 gel filtration, RP-HPLC C-8 column chromatography, and Mono-Q column chromatography
-
by ammonium sulfate and ethanol precipitation and gel filtration, to homogeneity, 250fold. Overall recovery of phospholipase activity is about 82%
-
by ammonium sulfate and ethanol precipitation, followed by gel filtration and gel filtration, to homogeneity, with a yield of 16%, 2000fold
-
by centrifugation and gel filtration
by centrifugation and on anion-exchange column
by centrifugation and on nickel-nitrilotriacetic acid column
-
by centrifugation, sonication and gel filtration
by gel filtration
by gel filtration and ammonium acetate precipitation
-
by gel filtration followed by reverse phase high performance liquid chromatography
-
by single-step cation-exchange chromatography
-
C8 Sepharose column chromatography, C18 Sepharose column chromatography, and Superdex G-75 gel filtration
-
cation exchange column, reversed phase HPLC
-
CM-Sepharose column chromatography and phenyl-Sepharose column chromatography
-
column chromatography
column chromatography steps
-
column chromatography steps, 11700fold
-
column chromatography, 15fold
-
column chromatography, 4500fold
-
column chromatography, electrophoresis, EC-IV-PLA2, 2.3fold
-
column chromatography, gel electrophoresis, 1206fold
-
column chromatography, immunoadsorbent column containing group II PLA2-antibodies, 735fold
-
column chromatography, isoelectric focusing, 113fold
-
column chromatography, Oh-DE-2, Oh-DE-5 and Oh-DE-6
-
cPLA2s and sPLA2s
dialysis, column chromatography
-
enzyme from venom by gel filtration and ion exchange chromatography
fast protein liquid chromatography
-
from crude venom
-
from soluble venom by high performance liquid chromatography, to homogeneity
-
gamma-Bondapack C18 column chromatography
-
gel chromatography
-
gel filtration
-
gel filtration chromatography
-
gel filtration chromatography, more than 100fold
-
gel filtration, affinity chromatography
-
gel filtration, affinity chromatography, 2835fold
-
gel filtration, at least 98% pure
-
gel filtration, column chromatography
-
gel permeation chromatography, reverse-phase HPLC, cation-exchange FPLC
-
GVIA PLA2
-
homogenous state
-
ion exchange chromatography
ion-exchange chromatography, gel filtration, 16.3fold
-
ion-exchange chromatography, gel-filtration
-
ion-exchange chromatography, gel-filtration chromatography, hydroxyapatite chromatography, 72500fold
-
ion-exchange chromatography, gel-filtration chromatography,167fold
-
ion-exchange chromatography, gel-filtration, 11fold
-
isoenzyme b-PLA2, ion-exchange chromatography
-
isoenzyme NK-PLA2-II
-
isoforms G-1 PLA2, G-1 PLA2, G-3 PLA2
-
lysosomal cPLA2 isozyme from brain
-
mu-Bondapack C18 column chromatography and Superdex 75 gel filtration
-
native enzyme 2000fold from delipidated pancreas by heat and acid treatment at 70°C and pH 3.0, ammonium sulfate fractionation, ethanol precipitation, gel filtration, anion and cation exchange chromatography, and reversed phase chromatography
-
native enzyme 280fold from delipidated pancreas by heat treatment at 70°C, ammonium sulfate and ethanol fractionation, anion exchange chromatography, and gel filtration to homogeneity
-
native enzyme by gel filtration and C18 reverse phase HPLC
-
native enzyme from venom by cation and anion exchange chromatography
-
native enzyme from venom by gel filtration
native enzyme from venom by gel filtration and C18 reverse phase HPLC
-
native enzyme from venom by gel filtration and C8 reverse phase HPLC
-
native enzyme from venom by gel filtration to homogeneity
native enzyme RVV-7 from venom purified to homogeneity after partial unfolding by 4 M urea followed by ultrafiltration and dialysis
-
native PLA2 from venom in several chromatographic steps, including gel filtration and anion exchange chromatography, to over 95% puritiy
-
Ni-NTA affinity chromatography
Ni-NTA resin column chromatography
on CM ion exchange resin, over 90% pure
p-bromophenacyl bromide modified enzyme, column chromatography
-
partial purification, 176fold
-
partial, the phospholipase A2 is difficult to purify by general chromatography because of aggregation
-
partially purified by gel filtration and on anion exchange column
-
recombinant AtsPLA2-alpha solubilized from Escherichia coli strain Bl21(DE3) inclusion bodies to homogeneity by gel filtration and anion exchange chromatography
-
recombinant C-terminally His6-tagged Lp-PLA2 from Pichia pastoris by nickel affinity chromatography
recombinant full-length wild-type and mutant cPLA2alphas containing the affinity peptide YHHHHHH
-
recombinant GST-tagged isozyme IPLA-1 from Escherichia coli strain Rosetta2 (DE3) by glutathione affinity chromatography and gel filtration
-
recombinant His-tagged enzyme by nickel affinity chromatography and gel filtration
-
recombinant human group IIA PLA2isozyme and isozyme hIBPLA2 from Escherichia coli strain BL21(DE3)
recombinant solubilized secreted phospholipase A2 to homogeneity
-
recombinant solubilized wild-type and mutant enzymes from Escherichia coli strain BL21(DE3) by heparin affinity chromatography and gel filtration to homogeneity
-
recombinant tagged cPLA2 from Spodoptera frugiperda okadaic acid-treated Sf9 cells
-
recombinant untagged enzyme by ion-exchange chromatography and gel filtration
-
recombinant wild-type and mutant enzymes, after solubilization from Escherichia coli inclusion bodies, by anion exchange chromatography and gel filtration to homogeneity
reverse phase C18-mu-Nova pack column chromatography, CM Sephadex C-50 gel filtration and DEAE Sephadex A-50 gel filtration
-
reverse-phase HPLC, gel filtration, from gastric juice, 180fold
-
reverse-phase HPLC, gel filtration, from gastric mucosa, 51.5fold
-
reverse-phase HPLC, gel filtration, from pancreas, more than 34.7fold
-
semipurification, heparin-Sepharose affinity chromatography
-
Sephadex G-75 gel filtration and cation-exchange chromatography
-
subcellular fractionation
-
tandem affinity chromatographies
-
to homogeneity by gel filtration and reverse-phase chromatography
Vydac C18 HPLC column chromatography and Sephadex G-75 gel filtration
-